Ikarian Capital, LLC Vericel Corp Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Vericel Corp stock. As of the latest transaction made, Ikarian Capital, LLC holds 7,900 shares of VCEL stock, worth $322,873. This represents 0.03% of its overall portfolio holdings.
Number of Shares
7,900Holding current value
$322,873% of portfolio
0.03%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
290Shares Held
49.5MCall Options Held
98.2KPut Options Held
135K-
Black Rock Inc. New York, NY8.06MShares$329 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.49MShares$142 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.24MShares$132 Million4.21% of portfolio
-
State Street Corp Boston, MA2.4MShares$98.3 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.24MShares$91.5 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $1.93B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...